Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03592173 · ClinicalTrials.gov registry record · Phase 2

Non-Invasive Stimulation for Improving Motor Function

A Phase 2 study of Spinal Cord Injuries, sponsored by Kathleen Friel.

Active
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT03592173: Active Phase 2 study of Spinal Cord Injuries, sponsored by Kathleen Friel.

NCT03592173 is a Phase 2 study of Spinal Cord Injuries that is active but no longer recruiting, run by Kathleen Friel. The registered enrollment target is 30 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03592173, a Phase 2 study of Spinal Cord Injuries, is active but no longer recruiting, sponsored by Kathleen Friel.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if spinal excitability is increased with a Spinal Associative Stimulation (SAS) protocol, and to determine the functional consequences of this technique on motor recovery.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Paired TMS & Peripheral Nerve Stimulation

Study Locations (1)

New York

  • Burke Medical Research Institute - White Plains

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-07
Est. Completion 2025-12
Phase Phase 2
Kathleen Friel

2 total trials

What the registry record for NCT03592173 still lists

NCT03592173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Paired TMS & Peripheral Nerve Stimulation is the first listed.

NCT03592173 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03592173 about?

NCT03592173 is a clinical study titled "Non-Invasive Stimulation for Improving Motor Function". The purpose of this study is to determine if spinal excitability is increased with a Spinal Associative Stimulation (SAS) protocol, and to determine the functional consequences of this technique on motor recovery.

What is the current status of trial NCT03592173?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2013-07. Estimated completion is 2025-12.

What conditions does trial NCT03592173 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT03592173?

The interventions under investigation include: Paired TMS & Peripheral Nerve Stimulation (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03592173?

This trial is sponsored by Kathleen Friel, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03592173 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03592173's enrollment target sits among peer trials

30 90th of 202 higher than 99 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03592173, the US trial registry maintained by the National Library of Medicine. NCT03592173 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.